$28.26
-0.230 (-0.81%)
At Close: Jun 03, 2026
STAA Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of STAAR Surgical to Alcon
01:28pm, Tuesday, 05'th Aug 2025
MONSEY, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of STAAR Surgical Company (Nasdaq: STAA) (“STAAR”) to Alcon,
Shareholder Alert: The Ademi Firm investigates whether STAAR Surgical Company is obtaining a Fair Price for its Public Shareholders
11:23am, Tuesday, 05'th Aug 2025
MILWAUKEE , Aug. 5, 2025 /PRNewswire/ -- The Ademi Firm is investigating STAAR (NASDAQ: STAA) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon Inc. Cli
Top 2 Health Care Stocks You May Want To Dump In Q3
09:11am, Tuesday, 05'th Aug 2025
As of Aug. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
STAA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of STAAR Surgical Company Is Fair to Shareholders
07:37am, Tuesday, 05'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of STAAR Surgical Company (NASDAQ: STAA) to Alcon for $28.00 per share in cash is fair to ST
STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025
10:03pm, Thursday, 31'st Jul 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical Announces Participation in Upcoming Investor Conferences
07:00am, Thursday, 22'nd May 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical Announces $30 Million Share Repurchase Authorization
07:00am, Friday, 16'th May 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical Q1: Clouded Outlook Warrants Caution (Rating Downgrade)
04:08am, Wednesday, 14'th May 2025
Sales in China were severely impacted due to inventory de-stocking, but the outlook for the region for H2 2025 looks promising. Global sales ex-China were weak, with management choosing to withdraw th
STAAR Surgical Company (STAA) Q1 2025 Earnings Call Transcript
11:51pm, Wednesday, 07'th May 2025
STAAR Surgical Company. (NASDAQ:STAA ) Q1 2025 Earnings Conference Call May 7, 2025 5:15 PM ET Company Participants Brian Moore - VP, Investor Relations and Corporate Development Stephen Farrell - Cha
Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
08:05pm, Wednesday, 07'th May 2025
Although the revenue and EPS for Staar Surgical (STAA) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall
Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates
06:45pm, Wednesday, 07'th May 2025
Staar Surgical (STAA) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to earnings of $0.06 per share a year ago.
STAAR Surgical Reports First Quarter 2025 Results
04:01pm, Wednesday, 07'th May 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical Announces Changes to Board of Directors
05:00pm, Thursday, 24'th Apr 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025
07:00am, Wednesday, 23'rd Apr 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
Sign In
Buy STAA